Proportions of CD4 test results indicating advanced HIV disease remain consistently high at primary health care facilities across four high HIV burden countries.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • Publication Information:
      Original Publication: San Francisco, CA : Public Library of Science
    • Subject Terms:
    • Abstract:
      Background: Globally, nearly 22 million HIV-infected patients are currently accessing antiretroviral treatment; however, almost one million people living with HIV died of AIDS-related illnesses in 2018. Advanced HIV disease remains a significant issue to curb HIV-related mortality.
      Methods: We analyzed 864,389 CD4 testing records collected by 1,016 Alere Pima Analyzers implemented at a variety of facilities, including peripheral facilities, between January 2012 and December 2016 across four countries in sub-Saharan Africa. Routinely collected data and programmatic records were used to analyze the median CD4 counts and proportions of patients with advanced HIV disease by country, facility type, and year.
      Results: Median CD4 counts were between 409-444 cells/ul each year since 2012 with a median in 2016 of 444 cells/ul (n = 319,829). The proportion of test results returning CD4 counts above 500 cells/ul has increased slowly each year with 41.8% (95% CI: 41.6-41.9%) of tests having a CD4 count above 500 cells/ul in 2016. Median CD4 counts were similar across facility types. The proportion of test results indicating advanced HIV disease has remained fairly consistent: 19.4% (95% CI: 18.8-20.1%) in 2012 compared to 16.1% (95% CI: 16.0-16.3%) in 2016. The proportion of test results indicating advanced HIV disease annually ranged from 14.5% in Uganda to 29.8% in Cameroon. 6.9% (95% CI: 6.8-7.0%) of test results showed very advanced HIV disease (CD4<100 cells/ul) in 2016.
      Conclusions: The proportion of CD4 test results indicating advanced disease was relatively high and consistent across four high HIV burden countries.
      Competing Interests: The authors have declared that no competing interests exist.
    • References:
      Clin Infect Dis. 2018 Mar 4;66(suppl_2):S111-S117. (PMID: 29514238)
      Clin Infect Dis. 2018 Mar 4;66(suppl_2):S118-S125. (PMID: 29514233)
      N Engl J Med. 2017 Jul 20;377(3):233-245. (PMID: 28723333)
      Clin Infect Dis. 2018 Mar 4;66(suppl_2):S132-S139. (PMID: 29514234)
      Clin Infect Dis. 2018 Mar 4;66(suppl_2):S103-SS105. (PMID: 29514231)
      Clin Infect Dis. 2016 Jun 15;62(12):1595-1603. (PMID: 26951573)
      Lancet HIV. 2015 Oct;2(10):e438-44. (PMID: 26423651)
      Clin Infect Dis. 2018 Mar 4;66(suppl_2):S106-SS110. (PMID: 29514232)
      Lancet. 2015 May 30;385(9983):2173-82. (PMID: 25765698)
      Clin Infect Dis. 2018 Mar 5;66(6):893-903. (PMID: 29373672)
      PLoS Med. 2016 Aug 23;13(8):e1002088. (PMID: 27551917)
      Clin Infect Dis. 2018 Mar 4;66(suppl_2):S126-S131. (PMID: 29514239)
      Clin Infect Dis. 2012 Dec;55(12):1707-18. (PMID: 22972859)
    • Grant Information:
      R01 AI122991 United States AI NIAID NIH HHS
    • Publication Date:
      Date Created: 20200108 Date Completed: 20200420 Latest Revision: 20200420
    • Publication Date:
      20240105
    • Accession Number:
      PMC6946176
    • Accession Number:
      10.1371/journal.pone.0226987
    • Accession Number:
      31910221